Naloxone and Patient Outcomes in Out-of-Hospital Cardiac Arrests in California

The incidence of opioid-associated out-of-hospital cardiac arrest (OA-OHCA) has grown from less than 1% of OHCA in 2000 to between 7% and 14% of OHCA in recent years; American Heart Association (AHA) protocols suggest that emergency medical service (EMS) clinicians consider naloxone in OA-OHCA. Howe...

Full description

Saved in:
Bibliographic Details
Published inJAMA network open Vol. 7; no. 8; p. e2429154
Main Authors Dillon, David G, Montoy, Juan Carlos C, Nishijima, Daniel K, Niederberger, Sara, Menegazzi, James J, Lacocque, Jeremy, Rodriguez, Robert M, Wang, Ralph C
Format Journal Article
LanguageEnglish
Published United States American Medical Association 01.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The incidence of opioid-associated out-of-hospital cardiac arrest (OA-OHCA) has grown from less than 1% of OHCA in 2000 to between 7% and 14% of OHCA in recent years; American Heart Association (AHA) protocols suggest that emergency medical service (EMS) clinicians consider naloxone in OA-OHCA. However, it is unknown whether naloxone improves survival in these patients or in patients with undifferentiated OHCA. To evaluate the association of naloxone with clinical outcomes in patients with undifferentiated OHCA. Retrospective cohort study of EMS-treated patients aged 18 or older who received EMS treatment for nontraumatic OHCA in 3 Northern California counties between 2015 and 2023. Data were analyzed using propensity score-based models from February to April 2024. EMS administration of naloxone. The primary outcome was survival to hospital discharge; the secondary outcome was sustained return of spontaneous circulation (ROSC). Covariates included patient and cardiac arrest characteristics (eg, age, sex, nonshockable rhythm, any comorbidity, unwitnessed arrest, and EMS agency) and EMS clinician determination of OHCA cause as presumed drug-related. Among 8195 patients (median [IQR] age, 65 [51-78] years; 5540 male [67.6%]; 1304 Asian, Native Hawaiian, or Pacific Islander [15.9%]; 1119 Black [13.7%]; 2538 White [31.0%]) with OHCA treated by 5 EMS agencies from 2015 to 2023, 715 (8.7%) were believed by treating clinicians to have drug-related OHCA. Naloxone was administered to 1165 patients (14.2%) and was associated with increased ROSC using both nearest neighbor propensity matching (absolute risk difference [ARD], 15.2%; 95% CI, 9.9%-20.6%) and inverse propensity-weighted regression adjustment (ARD, 11.8%; 95% CI, 7.3%-16.4%). Naloxone was also associated with increased survival to hospital discharge using both nearest neighbor propensity matching (ARD, 6.2%; 95% CI, 2.3%-10.0%) and inverse propensity-weighted regression adjustment (ARD, 3.9%; 95% CI, 1.1%-6.7%). The number needed to treat with naloxone was 9 for ROSC and 26 for survival to hospital discharge. In a regression model that assessed effect modification between naloxone and presumed drug-related OHCA, naloxone was associated with improved survival to hospital discharge in both the presumed drug-related OHCA (odds ratio [OR], 2.48; 95% CI, 1.34-4.58) and non-drug-related OHCA groups (OR, 1.35; 95% CI, 1.04-1.77). In this retrospective cohort study, naloxone administration as part of EMS management of OHCA was associated with increased rates of ROSC and increased survival to hospital discharge when evaluated using propensity score-based models. Given the lack of clinical practice data on the efficacy of naloxone in OA-OHCA and OHCA in general, these findings support further evaluation of naloxone as part of cardiac arrest care.
AbstractList ImportanceThe incidence of opioid-associated out-of-hospital cardiac arrest (OA-OHCA) has grown from less than 1% of OHCA in 2000 to between 7% and 14% of OHCA in recent years; American Heart Association (AHA) protocols suggest that emergency medical service (EMS) clinicians consider naloxone in OA-OHCA. However, it is unknown whether naloxone improves survival in these patients or in patients with undifferentiated OHCA.ObjectiveTo evaluate the association of naloxone with clinical outcomes in patients with undifferentiated OHCA.Design, Setting, and ParticipantsRetrospective cohort study of EMS-treated patients aged 18 or older who received EMS treatment for nontraumatic OHCA in 3 Northern California counties between 2015 and 2023. Data were analyzed using propensity score-based models from February to April 2024.ExposureEMS administration of naloxone.Main Outcomes and MeasuresThe primary outcome was survival to hospital discharge; the secondary outcome was sustained return of spontaneous circulation (ROSC). Covariates included patient and cardiac arrest characteristics (eg, age, sex, nonshockable rhythm, any comorbidity, unwitnessed arrest, and EMS agency) and EMS clinician determination of OHCA cause as presumed drug-related.ResultsAmong 8195 patients (median [IQR] age, 65 [51-78] years; 5540 male [67.6%]; 1304 Asian, Native Hawaiian, or Pacific Islander [15.9%]; 1119 Black [13.7%]; 2538 White [31.0%]) with OHCA treated by 5 EMS agencies from 2015 to 2023, 715 (8.7%) were believed by treating clinicians to have drug-related OHCA. Naloxone was administered to 1165 patients (14.2%) and was associated with increased ROSC using both nearest neighbor propensity matching (absolute risk difference [ARD], 15.2%; 95% CI, 9.9%-20.6%) and inverse propensity–weighted regression adjustment (ARD, 11.8%; 95% CI, 7.3%-16.4%). Naloxone was also associated with increased survival to hospital discharge using both nearest neighbor propensity matching (ARD, 6.2%; 95% CI, 2.3%-10.0%) and inverse propensity–weighted regression adjustment (ARD, 3.9%; 95% CI, 1.1%-6.7%). The number needed to treat with naloxone was 9 for ROSC and 26 for survival to hospital discharge. In a regression model that assessed effect modification between naloxone and presumed drug-related OHCA, naloxone was associated with improved survival to hospital discharge in both the presumed drug-related OHCA (odds ratio [OR], 2.48; 95% CI, 1.34-4.58) and non–drug-related OHCA groups (OR, 1.35; 95% CI, 1.04-1.77).Conclusions and RelevanceIn this retrospective cohort study, naloxone administration as part of EMS management of OHCA was associated with increased rates of ROSC and increased survival to hospital discharge when evaluated using propensity score–based models. Given the lack of clinical practice data on the efficacy of naloxone in OA-OHCA and OHCA in general, these findings support further evaluation of naloxone as part of cardiac arrest care.
This cohort study evaluates the association of naloxone administration with clinical outcomes in patients with out-of-hospital cardiac arrests in California.
The incidence of opioid-associated out-of-hospital cardiac arrest (OA-OHCA) has grown from less than 1% of OHCA in 2000 to between 7% and 14% of OHCA in recent years; American Heart Association (AHA) protocols suggest that emergency medical service (EMS) clinicians consider naloxone in OA-OHCA. However, it is unknown whether naloxone improves survival in these patients or in patients with undifferentiated OHCA.ImportanceThe incidence of opioid-associated out-of-hospital cardiac arrest (OA-OHCA) has grown from less than 1% of OHCA in 2000 to between 7% and 14% of OHCA in recent years; American Heart Association (AHA) protocols suggest that emergency medical service (EMS) clinicians consider naloxone in OA-OHCA. However, it is unknown whether naloxone improves survival in these patients or in patients with undifferentiated OHCA.To evaluate the association of naloxone with clinical outcomes in patients with undifferentiated OHCA.ObjectiveTo evaluate the association of naloxone with clinical outcomes in patients with undifferentiated OHCA.Retrospective cohort study of EMS-treated patients aged 18 or older who received EMS treatment for nontraumatic OHCA in 3 Northern California counties between 2015 and 2023. Data were analyzed using propensity score-based models from February to April 2024.Design, Setting, and ParticipantsRetrospective cohort study of EMS-treated patients aged 18 or older who received EMS treatment for nontraumatic OHCA in 3 Northern California counties between 2015 and 2023. Data were analyzed using propensity score-based models from February to April 2024.EMS administration of naloxone.ExposureEMS administration of naloxone.The primary outcome was survival to hospital discharge; the secondary outcome was sustained return of spontaneous circulation (ROSC). Covariates included patient and cardiac arrest characteristics (eg, age, sex, nonshockable rhythm, any comorbidity, unwitnessed arrest, and EMS agency) and EMS clinician determination of OHCA cause as presumed drug-related.Main Outcomes and MeasuresThe primary outcome was survival to hospital discharge; the secondary outcome was sustained return of spontaneous circulation (ROSC). Covariates included patient and cardiac arrest characteristics (eg, age, sex, nonshockable rhythm, any comorbidity, unwitnessed arrest, and EMS agency) and EMS clinician determination of OHCA cause as presumed drug-related.Among 8195 patients (median [IQR] age, 65 [51-78] years; 5540 male [67.6%]; 1304 Asian, Native Hawaiian, or Pacific Islander [15.9%]; 1119 Black [13.7%]; 2538 White [31.0%]) with OHCA treated by 5 EMS agencies from 2015 to 2023, 715 (8.7%) were believed by treating clinicians to have drug-related OHCA. Naloxone was administered to 1165 patients (14.2%) and was associated with increased ROSC using both nearest neighbor propensity matching (absolute risk difference [ARD], 15.2%; 95% CI, 9.9%-20.6%) and inverse propensity-weighted regression adjustment (ARD, 11.8%; 95% CI, 7.3%-16.4%). Naloxone was also associated with increased survival to hospital discharge using both nearest neighbor propensity matching (ARD, 6.2%; 95% CI, 2.3%-10.0%) and inverse propensity-weighted regression adjustment (ARD, 3.9%; 95% CI, 1.1%-6.7%). The number needed to treat with naloxone was 9 for ROSC and 26 for survival to hospital discharge. In a regression model that assessed effect modification between naloxone and presumed drug-related OHCA, naloxone was associated with improved survival to hospital discharge in both the presumed drug-related OHCA (odds ratio [OR], 2.48; 95% CI, 1.34-4.58) and non-drug-related OHCA groups (OR, 1.35; 95% CI, 1.04-1.77).ResultsAmong 8195 patients (median [IQR] age, 65 [51-78] years; 5540 male [67.6%]; 1304 Asian, Native Hawaiian, or Pacific Islander [15.9%]; 1119 Black [13.7%]; 2538 White [31.0%]) with OHCA treated by 5 EMS agencies from 2015 to 2023, 715 (8.7%) were believed by treating clinicians to have drug-related OHCA. Naloxone was administered to 1165 patients (14.2%) and was associated with increased ROSC using both nearest neighbor propensity matching (absolute risk difference [ARD], 15.2%; 95% CI, 9.9%-20.6%) and inverse propensity-weighted regression adjustment (ARD, 11.8%; 95% CI, 7.3%-16.4%). Naloxone was also associated with increased survival to hospital discharge using both nearest neighbor propensity matching (ARD, 6.2%; 95% CI, 2.3%-10.0%) and inverse propensity-weighted regression adjustment (ARD, 3.9%; 95% CI, 1.1%-6.7%). The number needed to treat with naloxone was 9 for ROSC and 26 for survival to hospital discharge. In a regression model that assessed effect modification between naloxone and presumed drug-related OHCA, naloxone was associated with improved survival to hospital discharge in both the presumed drug-related OHCA (odds ratio [OR], 2.48; 95% CI, 1.34-4.58) and non-drug-related OHCA groups (OR, 1.35; 95% CI, 1.04-1.77).In this retrospective cohort study, naloxone administration as part of EMS management of OHCA was associated with increased rates of ROSC and increased survival to hospital discharge when evaluated using propensity score-based models. Given the lack of clinical practice data on the efficacy of naloxone in OA-OHCA and OHCA in general, these findings support further evaluation of naloxone as part of cardiac arrest care.Conclusions and RelevanceIn this retrospective cohort study, naloxone administration as part of EMS management of OHCA was associated with increased rates of ROSC and increased survival to hospital discharge when evaluated using propensity score-based models. Given the lack of clinical practice data on the efficacy of naloxone in OA-OHCA and OHCA in general, these findings support further evaluation of naloxone as part of cardiac arrest care.
The incidence of opioid-associated out-of-hospital cardiac arrest (OA-OHCA) has grown from less than 1% of OHCA in 2000 to between 7% and 14% of OHCA in recent years; American Heart Association (AHA) protocols suggest that emergency medical service (EMS) clinicians consider naloxone in OA-OHCA. However, it is unknown whether naloxone improves survival in these patients or in patients with undifferentiated OHCA. To evaluate the association of naloxone with clinical outcomes in patients with undifferentiated OHCA. Retrospective cohort study of EMS-treated patients aged 18 or older who received EMS treatment for nontraumatic OHCA in 3 Northern California counties between 2015 and 2023. Data were analyzed using propensity score-based models from February to April 2024. EMS administration of naloxone. The primary outcome was survival to hospital discharge; the secondary outcome was sustained return of spontaneous circulation (ROSC). Covariates included patient and cardiac arrest characteristics (eg, age, sex, nonshockable rhythm, any comorbidity, unwitnessed arrest, and EMS agency) and EMS clinician determination of OHCA cause as presumed drug-related. Among 8195 patients (median [IQR] age, 65 [51-78] years; 5540 male [67.6%]; 1304 Asian, Native Hawaiian, or Pacific Islander [15.9%]; 1119 Black [13.7%]; 2538 White [31.0%]) with OHCA treated by 5 EMS agencies from 2015 to 2023, 715 (8.7%) were believed by treating clinicians to have drug-related OHCA. Naloxone was administered to 1165 patients (14.2%) and was associated with increased ROSC using both nearest neighbor propensity matching (absolute risk difference [ARD], 15.2%; 95% CI, 9.9%-20.6%) and inverse propensity-weighted regression adjustment (ARD, 11.8%; 95% CI, 7.3%-16.4%). Naloxone was also associated with increased survival to hospital discharge using both nearest neighbor propensity matching (ARD, 6.2%; 95% CI, 2.3%-10.0%) and inverse propensity-weighted regression adjustment (ARD, 3.9%; 95% CI, 1.1%-6.7%). The number needed to treat with naloxone was 9 for ROSC and 26 for survival to hospital discharge. In a regression model that assessed effect modification between naloxone and presumed drug-related OHCA, naloxone was associated with improved survival to hospital discharge in both the presumed drug-related OHCA (odds ratio [OR], 2.48; 95% CI, 1.34-4.58) and non-drug-related OHCA groups (OR, 1.35; 95% CI, 1.04-1.77). In this retrospective cohort study, naloxone administration as part of EMS management of OHCA was associated with increased rates of ROSC and increased survival to hospital discharge when evaluated using propensity score-based models. Given the lack of clinical practice data on the efficacy of naloxone in OA-OHCA and OHCA in general, these findings support further evaluation of naloxone as part of cardiac arrest care.
Author Rodriguez, Robert M
Niederberger, Sara
Dillon, David G
Montoy, Juan Carlos C
Nishijima, Daniel K
Menegazzi, James J
Wang, Ralph C
Lacocque, Jeremy
AuthorAffiliation 1 Department of Emergency Medicine, University of California, Davis
3 Department of Emergency Medicine, University of Pittsburgh, Pennsylvania
2 Department of Emergency Medicine, University of California, San Francisco
AuthorAffiliation_xml – name: 3 Department of Emergency Medicine, University of Pittsburgh, Pennsylvania
– name: 1 Department of Emergency Medicine, University of California, Davis
– name: 2 Department of Emergency Medicine, University of California, San Francisco
Author_xml – sequence: 1
  givenname: David G
  surname: Dillon
  fullname: Dillon, David G
  organization: Department of Emergency Medicine, University of California, Davis
– sequence: 2
  givenname: Juan Carlos C
  surname: Montoy
  fullname: Montoy, Juan Carlos C
  organization: Department of Emergency Medicine, University of California, San Francisco
– sequence: 3
  givenname: Daniel K
  surname: Nishijima
  fullname: Nishijima, Daniel K
  organization: Department of Emergency Medicine, University of California, Davis
– sequence: 4
  givenname: Sara
  surname: Niederberger
  fullname: Niederberger, Sara
  organization: Department of Emergency Medicine, University of Pittsburgh, Pennsylvania
– sequence: 5
  givenname: James J
  surname: Menegazzi
  fullname: Menegazzi, James J
  organization: Department of Emergency Medicine, University of Pittsburgh, Pennsylvania
– sequence: 6
  givenname: Jeremy
  surname: Lacocque
  fullname: Lacocque, Jeremy
  organization: Department of Emergency Medicine, University of California, San Francisco
– sequence: 7
  givenname: Robert M
  surname: Rodriguez
  fullname: Rodriguez, Robert M
  organization: Department of Emergency Medicine, University of California, San Francisco
– sequence: 8
  givenname: Ralph C
  surname: Wang
  fullname: Wang, Ralph C
  organization: Department of Emergency Medicine, University of California, San Francisco
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39163042$$D View this record in MEDLINE/PubMed
BookMark eNpdkElP5DAQha0RiLX_AoqYC5c0ZZeX5DRCrWGREHCAc1TdcRj3JHbjJAz8e8wyqOFUT6pPr169Xbbhg7eMHXKYcgB-vKSOvB3-hfg3rKyfChByKkqu5A-2I5SRORagNtb0Npv0_RIABHAstdpi21hyjSDFDru6ojY8pRMZ-Tq7ocFZP2TX47AIne0z5191Hpr8PPQrN1CbzSjWjhbZSYy2H96QGbWuCdE72mebDbW9nXzMPXZ3-vt2dp5fXp9dzE4ucxKlHnJEIGtKU6NBoeYSuWwAjeSy4Kgb0SiNc2k5GaEQtLZUF3xeNNoAFFIp3GO_3n1X47yz9SKFjtRWq-g6is9VIFd93Xj3p7oPjxXniAa0TA5HHw4xPIzpk6pz_cK2bWo3jH2FUMpCmIQn9Oc3dBnG6NN_VQoulDRgXqmD9UifWf53jS9sw4Y5
ContentType Journal Article
Copyright 2024. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright 2024 Dillon DG et al. .
Copyright_xml – notice: 2024. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright 2024 Dillon DG et al. .
DBID CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
5PM
DOI 10.1001/jamanetworkopen.2024.29154
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Naloxone and Patient Outcomes in Out-of-Hospital Cardiac Arrests in California
EISSN 2574-3805
ExternalDocumentID 39163042
Genre Journal Article
GeographicLocations California
GeographicLocations_xml – name: California
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: K38 HL165363
GroupedDBID 0R~
53G
7X7
8FI
8FJ
ABUWG
ADBBV
ADPDF
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMJDE
BCNDV
BENPR
CCPQU
CGR
CUY
CVF
EBS
ECM
EIF
EMOBN
FYUFA
GROUPED_DOAJ
HMCUK
M~E
NPM
OK1
OVD
OVEED
PIMPY
RAJ
TEORI
UKHRP
W2D
H13
K9.
7X8
5PM
ID FETCH-LOGICAL-a296t-330ae797d37325b4314f0374148136f2f563b4e1a7253066ead81b8f670084553
ISSN 2574-3805
IngestDate Fri Aug 23 07:11:28 EDT 2024
Thu Dec 05 22:52:10 EST 2024
Tue Dec 10 11:11:02 EST 2024
Sat Nov 02 11:58:45 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License This is an open access article distributed under the terms of the CC-BY License.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a296t-330ae797d37325b4314f0374148136f2f563b4e1a7253066ead81b8f670084553
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1001/jamanetworkopen.2024.29154
PMID 39163042
PQID 3142547073
PQPubID 5319538
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11337064
proquest_miscellaneous_3094827133
proquest_journals_3142547073
pubmed_primary_39163042
PublicationCentury 2000
PublicationDate 2024-Aug-01
PublicationDateYYYYMMDD 2024-08-01
PublicationDate_xml – month: 08
  year: 2024
  text: 2024-Aug-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Chicago
PublicationTitle JAMA network open
PublicationTitleAlternate JAMA Netw Open
PublicationYear 2024
Publisher American Medical Association
Publisher_xml – sequence: 0
  name: American Medical Association
– name: American Medical Association
SSID ssj0002013965
Score 2.322054
Snippet The incidence of opioid-associated out-of-hospital cardiac arrest (OA-OHCA) has grown from less than 1% of OHCA in 2000 to between 7% and 14% of OHCA in recent...
ImportanceThe incidence of opioid-associated out-of-hospital cardiac arrest (OA-OHCA) has grown from less than 1% of OHCA in 2000 to between 7% and 14% of OHCA...
This cohort study evaluates the association of naloxone administration with clinical outcomes in patients with out-of-hospital cardiac arrests in California.
SourceID pubmedcentral
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage e2429154
SubjectTerms Adult
Aged
California - epidemiology
Cardiac arrest
Cardiopulmonary Resuscitation - methods
Cardiopulmonary Resuscitation - statistics & numerical data
Cohort analysis
Emergency Medical Services - statistics & numerical data
Emergency Medicine
Female
Humans
Male
Middle Aged
Naloxone - therapeutic use
Narcotic Antagonists - therapeutic use
Online Only
Original Investigation
Out-of-Hospital Cardiac Arrest - drug therapy
Out-of-Hospital Cardiac Arrest - epidemiology
Out-of-Hospital Cardiac Arrest - mortality
Patients
Retrospective Studies
Treatment Outcome
Title Naloxone and Patient Outcomes in Out-of-Hospital Cardiac Arrests in California
URI https://www.ncbi.nlm.nih.gov/pubmed/39163042
https://www.proquest.com/docview/3142547073
https://www.proquest.com/docview/3094827133
https://pubmed.ncbi.nlm.nih.gov/PMC11337064
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdp-rKXsbGvbF3wYG9BIbYky37sRkoZrTtGAnkzki0zj84eqcNK__rd2fJHsjC2vRhjyZLQ_Xy-O90HIe8TaeA3n2Y05EZTrkVGlUk19ZlO4W8DhNaoKF5H_uWaf9qIzWj0cxhdUul58nA0ruR_qArPgK4YJfsPlO0GhQdwD_SFK1AYrn9F40jdlvdlYV3-mwyps5tdBXPVflZ4T8uMtsVB0L0D8JDMzuuSHHWXPjhrT04FXjwrGhfxGVbY6gTevD2or73h-9Jc15gIoSl_vFM47Pa2vOttsBHaur7l31Uf195bWKMcU1qgp5ktA6a2amiO8HjnDFcNIgAG50yHKDM1bwNGwSkLFmLIiOUAb8GAqRoQI0K3yTX9G8fvKw3YTcE9mePK5t1L-2m2o5v4Yn11Fa-Wm9UJOcUMinxMTj8so89fOvOch6KxL7o0tU2equNTHFNODn1sB0LL6gl5bLUN57yBzlMyMsUzErWwcQA2joWN08LGyQvnADaOhY1jYYNdetg8J-uL5erjJbVlNajyQr-ijC2UkaFMmWSe0CBB8gyzEIFi7DI_8zIBHyo3rpKeAIXSB14Duk2QYUBXwIVgL8i4gEW-Ik6iUhUERnh6EXLXlVrAEJJpN8kUg8YJOWt3JrbfzV0M83mCS_i3TMi7rhm4Gh5VwRaXO-gD4wUeGlAm5GWzkfGPJv1KjKHiaISbkGBvi7sOmDF9v6XIv9aZ010YUIIQ_vrP63pDHvXQPiPjarszb0H2rPSUnMiNnFq0TGsLzi_6PI4N
link.rule.ids 230,314,780,784,864,885,27924,27925,31719,31720,33744,33745
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Naloxone+and+Patient+Outcomes+in+Out-of-Hospital+Cardiac+Arrests+in+California&rft.jtitle=JAMA+network+open&rft.au=Dillon%2C+David+G&rft.au=Montoy%2C+Juan+Carlos+C&rft.au=Nishijima%2C+Daniel+K&rft.au=Niederberger%2C+Sara&rft.date=2024-08-01&rft.pub=American+Medical+Association&rft.eissn=2574-3805&rft.volume=7&rft.issue=8&rft.spage=e2429154&rft_id=info:doi/10.1001%2Fjamanetworkopen.2024.29154&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2574-3805&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2574-3805&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2574-3805&client=summon